Benjamin Berger

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 8

Top Topics

Squamous Cell Carcinoma

Top Venues

Journal of clinical pharmacology

Clinical and translational science

Pharmacology research & perspectives

This page only lists publications with an associated author ORCID identifier.

Publications

Massimo Magliocca, Benjamin Berger, Vincent Lemoine, Priska Kaufmann, Jasper Dingemanse
Value of Assessing 1-Hydroxymidazolam in Drug-Drug Interaction Studies with Midazolam as a Substrate of Cytochrome P450 3A. Journal of clinical pharmacology (2024)
Massimo Magliocca, Benjamin Berger, Vincent Lemoine, Priska Kaufmann, Jasper Dingemanse
Value of Assessing 1-Hydroxymidazolam in Drug-Drug Interaction Studies with Midazolam as a Substrate of Cytochrome P450 3A. Journal of clinical pharmacology 64 (9) (2024)
Benjamin Berger, Priska Kaufmann, Matthias Berse, Alexander Treiber, Nathalie Grignaschi, Jasper Dingemanse
Effect of nivasorexant (ACT-539313), a selective orexin-1-receptor antagonist, on multiple cytochrome P450 probe substrates in vitro and in vivo using a cocktail approach in healthy subjects. Pharmacology research & perspectives 11 (5) (2023)
Marion Anliker-Ort, Jasper Dingemanse, Stephane Delahaye, Luboš Janů, John van den Anker, Benjamin Berger, Priska Kaufmann
Evaluation of the cytochrome P450 2C19 and 3A4 inhibition potential of the complement factor 5a receptor antagonist ACT-1014-6470 in vitro and in vivo. Clinical and translational science (2023)
Benjamin Berger, Jasper Dingemanse, Giancarlo Sabattini, Stéphane Delahaye, Urs Duthaler, Clemens Muehlan, Stephan Krähenbühl
Effect of Liver Cirrhosis on the Pharmacokinetics, Metabolism, and Tolerability of Daridorexant, A Novel Dual Orexin Receptor Antagonist. Clinical pharmacokinetics 60 (10) (2021)
Benjamin Berger, Clemens Muehlan, Gernot Klein, Jasper Dingemanse
Pharmacokinetics of daridorexant, a dual orexin receptor antagonist, are not affected by renal impairment. Clinical and translational science 14 (6) (2021)
Benjamin Berger, Sander Brooks, Rob G J A Zuiker, Muriel Richard, Clemens Muehlan, Jasper Dingemanse
Pharmacological Interactions between the Dual Orexin Receptor Antagonist Daridorexant and Ethanol in a Double-Blind, Randomized, Placebo-Controlled, Double-Dummy, Four-Way Crossover Phase I Study in Healthy Subjects. CNS drugs 34 (12) (2020)
Benjamin Berger, Priska Kaufmann, Annelize Koch, Jasper Dingemanse
Impact of the Selective Orexin-1 Receptor Antagonist ACT-539313 on the Pharmacokinetics of the CYP3A Probe Drug Midazolam in Healthy Male Subjects. Journal of clinical pharmacology 60 (7) (2020)